MILBACTOR 16 MG/40 MG FILM-COATED TABLETS FOR CATS WEIGHING AT LEAST 2 KG

Nchi: Ayalandi

Lugha: Kiingereza

Chanzo: HPRA (Health Products Regulatory Authority)

Nunua Sasa

Tabia za bidhaa Tabia za bidhaa (SPC)
09-12-2016

Viambatanisho vya kazi:

MILBEMYCIN OXIME, PRAZIQUANTEL

Inapatikana kutoka:

Krka, d.d., Novo mesto

ATC kanuni:

QP54AB51

INN (Jina la Kimataifa):

MILBEMYCIN OXIME, PRAZIQUANTEL

Kipimo:

16.0/40.0

Dawa fomu:

Film Coated Tablet

Dawa ya aina:

POM

Kundi la matibabu:

Feline

Eneo la matibabu:

Milbemycin, combinations

Matibabu dalili:

Ectoparasiticide

Idhini hali ya:

Authorised

Idhini ya tarehe:

2015-02-13

Tabia za bidhaa

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milbactor 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains:
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet.
Brown red, oval, biconvex film-coated tablets with score line on one side.
The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats (weighing at least 2 kg).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats: treatment of mixed infections by immature and adult cestodes and nematodes of the following species:
- Cestodes:
_Dipylidium caninum_
_Taenia _spp.
_Echinococcus multilocularis_
- Nematodes:
_Ancylostoma tubaeforme_
_Toxocara cati_
Prevention of heartworm disease (_Dirofilaria immitis_) if concomitant treatment against cestodes is indicated.
ACTIVE SUBSTANCES:
Milbemycin oxime
16
mg
Praziquantel
40
mg
EXCIPIENTS:
Iron Oxide, red (E172)
0.20 mg
Titanium dioxide (E171) 0.51 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 24/11/2016_
_CRN 7025056_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use in cats weighing less than 2 kg.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It is recommended to treat all the animals living in the same household concomitantly.
In order to develop an effective worm control programme local epidemiological information and the risk of exposure of
the cat should be taken into account.
When _D. caninum _infection is present, concomitant treatment against intermediate hosts, such as fleas and lice, should
be 
                                
                                Soma hati kamili